MedTrace Logo

Prevention of Cancer-associated Malnutrition Through Oral Nutritional Supplements

NCT02312674 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-12-09

No results posted yet for this study

Summary

The aim of the randomized controlled study is to determine effects of an adjusted amount of oral nutritional supplements on the quality of life, the nutritional status, side effects, and response to therapy, in patients with pancreatic and hepatocellular carcinoma receiving palliative therapy.

Conditions

Interventions

DIETARY_SUPPLEMENT

Oral nutritional supplement

Beginning with the start of palliative therapy, depending on the nutritional status, one, two, or three cans per day are ingested during a period of three months.

Sponsors & Collaborators

  • University Hospital Tuebingen

    collaborator OTHER

  • University of Hohenheim

    lead OTHER

Principal Investigators

  • Stephan C. Bischoff, MD, Prof. · Department of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany

  • Michael Bitzer, MD; Prof. · Department of Hepatology, Gastroenterology, Infectious Diseases, University Hospital Tübingen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02312674 on ClinicalTrials.gov